John Sprague Attorney-In-Fact Net Worth & Insider Trades

John Sprague Attorney-In-Fact - Director, T2 Biosystems, Inc

As of April 11, 2022

What is John Sprague Attorney-In-Fact's Net Worth?

The current estimated net worth of T2 Biosystems, Inc's Director, John Sprague Attorney-In-Fact, is estimated to be about $318.55K . John Sprague Attorney-In-Fact owns about 152,350 units of T2 Biosystems, Inc common stock. In the last 4 years at T2 Biosystems, Inc, John Sprague Attorney-In-Fact has sold an estimated value of $618.67K worth.

What is John Sprague Attorney-In-Fact's Past Insider Trading?

John Sprague Attorney-In-Fact's largest purchase order was 10,000 units , worth over $4.77K on April 11, 2022. John Sprague Attorney-In-Fact's largest sale order was 17,043 units , worth over $118.64K on June 8, 2018. In total, John Sprague Attorney-In-Fact has made about 26 transactions over 4 years of their time at T2 Biosystems, Inc. John Sprague Attorney-In-Fact usually trades in February, with the busiest year in 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was John Sprague Attorney-In-Fact's Salary in 2020?

As Director of T2 Biosystems, Inc, John Sprague Attorney-In-Fact has a total base salary of $72,906 . John Sprague Attorney-In-Fact received compensation valued at about $1,170,087 in 2020 after becoming Director. The vast majority of their compensation came in the form of stock awards of $74,999 , other compensation of $1,022,182 .

What is John Sprague Attorney-In-Fact's' Mailing Address?

  • Mailing address is T2 Biosystems, Inc. 101 Hartwell Ave Lexington MA 02421 MA

T2 Biosystems, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John Sperzel, 2020 $490,705 - - $2,571,384 $393,750 $3,000 $3,458,839
John McDonough, 2020 $72,906 - $74,999 - - $1,022,182 $1,170,087
John McDonough, 2019 $550,000 - $372,000 $478,728 $233,750 $3,000 $1,637,478
Alec Barclay, 2020 $340,000 - $25,675 $38,621 $234,600 $952 $639,848
Alec Barclay, 2019 $337,500 $35,000 $111,600 $348,834 $102,000 $2,900 $937,834
Anthony Pare, 2020 $325,000 - $20,738 $159,763 $185,250 $3,000 $693,751
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm

What are T2 Biosystems, Inc's Past Insider Trades?

T2 Biosystems, Inc's most recent insider trade came on April 11, 2022 by John Sperzel III who bought 30,000 units worth $15K . In the last 8 years, insiders at T2 Biosystems, Inc have sold an estimated value of $9.08M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer,  David Elsbree, Director,  and Terrence Michael Gibbs, General Counsel .

T2 Biosystems, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1